Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
post marketing
Biotech
Biogen to navigate an ethics minefield for post-approval trial
After the Aduhelm approval set a precedent for FDA clearance based on surrogate endpoints, all eyes will be on Biogen's post-approval study.
Amirah Al Idrus
Jun 23, 2021 8:54am
FDA warns Allergan over recalled breast implant safety studies
May 15, 2020 9:45am
FDA warns 2 breast implant makers as safety probe continues
Mar 20, 2019 10:54am
FDA to launch scientific review of implant biocompatibility
Mar 15, 2019 4:54pm
Bayer, FDA extend Essure postmarket safety study by 2 years
Dec 27, 2018 2:20pm
Alcon pulls eye micro-stent from market after new safety data
Aug 30, 2018 7:59am